Myanmar Genomics Innovation, a subsidiary of BGI Genomics, was established to provide advanced genomic and medical laboratory services in Myanmar. The company delivers high-quality reproductive health screening and precision medicine solutions using Next-Generation Sequencing (NGS) and BGI’s proprietary technologies.

It offers Non-Invasive Prenatal Testing (NIPT) under the NIFTY brand to screen for fetal chromosomal abnormalities such as Down syndrome, helping reduce the risk of miscarriage caused by unnecessary amniocentesis. In addition to reproductive health screening, Myanmar Genomics Innovation also provides a wide range of genetic testing and medical analysis services to support better health outcomes and innovation in Myanmar’s healthcare sector.